Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. In contrast, it is unclear to what extent people most in need of psychedelic therapies will benefit.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

AUGUST 10, 2021

Being able to commercially scale our dried flower, while supporting patient care and Canada House’s Veteran program across Canada is something that we are excited to do. As the Canadian medical cannabis market matures, coverage programs will help to ensure long-term sales growth for this segment. providing approx.

Seed-To-Sale 105

Seed-To-Sale Cultivation Patients Cannabis 105

Cannabis Law Report

JUNE 27, 2022

So this is going to be more of an issue for y’all who specialize in packaging premium bud for smoking. million in the first month following launch of the program. [link]. OR Heath Authority accepting applications from psilocybin training programs: [link]. But retail is OK! Smokable Hemp case Supreme Court. ” shorturl.at/fyXZ3.

Seed-To-Sale 52

Seed-To-Sale Hemp Retail Treatment 52

NORML

MARCH 29, 2019

Governor Jim Justice (R) of West Virginia signed legislation into law that allows financial institutions to provide banking services related to the state’s medical marijuana program. Late last week, the North Dakota State Senate overwhelmingly passed a measure to expand the state’s medical marijuana program. California.

Legislation 164

Legislation Decriminalization Hemp Patients 164

NORML

MARCH 22, 2019

Senate Bill 34 would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Click here to email your lawmakers in support of compassionate care programs. CA resident? CA resident? CO resident?

Legislation 134

Legislation Hemp Patients Compliance 134

Puff Puff Post

NOVEMBER 5, 2019

. “This filing follows the successful conclusion of an extensive preclinical development program that included 20 safety pharmacology and toxicology studies with treatment up to 28 days,” says Alexandra Mancini, Senior Vice President of Clinical and Regulatory Affairs. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

NORML

MARCH 15, 2019

Senate Bill 34 would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Click here to email your lawmakers in support of compassionate care programs. California. CA resident? CO resident?

Legislation 142

Legislation Hemp Compliance Compliance 142

The Joint Blog

OCTOBER 8, 2021

They offer effective treatment for anxiety & stress-related conditions without having any side effects on the body. Some vape pens come packaged with CBD and THC oils, allowing you to choose from your desired effect, most especially if you are not a fan of psychoactive effects. You can have a look into current CBD studies. .

Vaping 49

Vaping CBD Blood Pressure Chronic Pain 49

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Continued Protections for State Legal Medical Programs.

Legislation 59

Legislation Patients Access Banking 59

Cannabis Law Report

JULY 30, 2019

In my estimation, the state’s overall program growth in Florida to date is impressive. The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.”

Marijuana 40

Marijuana Education Patients Research and Development 40

Puff Puff Post

NOVEMBER 5, 2019

. “This filing follows the successful conclusion of an extensive preclinical development program that included 20 safety pharmacology and toxicology studies with treatment up to 28 days,” says Alexandra Mancini, Senior Vice President of Clinical and Regulatory Affairs. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

The Cannigma

FEBRUARY 16, 2022

So, I’m legitimately, I’m a strength conditioning coach. I was like, it’d be cool, if whatever rush you get, that runner’s high, that endorphin, I said, if you could get that and package it, and you could just take that on a regular basis as an athlete, wouldn’t that be amazing? And I kind of joked about it.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73